Pure Global
NCT06276322

Assessment of All Spine Segments ın Individuals With Low Back Pain

Assessment and Comparison of All Spinal Segments Kinematics ın Patients With Chronic Low Back Pain and Asymptomatic Individuals ın Three Planes During Activities of Daily Living
Hacettepe University·ClinicalTrials.gov·otherRecruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Low Back Pain
Drug/Device/Intervention
Low back pain group
Study type
Interventional
Intervention type
other
Sponsor & location
Primary sponsor
Hacettepe University
Location
Ankara, Turkey
Timeline & enrollment
Phase
N/A
Start date
Dec 01, 2023
End date
Dec 31, 2024
Enrollment
46 participants
Primary outcome

Evaluation of the kinematics of the all spine during walking,Evaluation of the kinematics of the all spine during Bending Forward and Lifting Objects,Evaluation of the kinematics of the all spine during Standing from Sitting,Evaluation of the kinematics of the all spine during Climbing Step

Summary

The aim of the study is to evaluate the kinematics of all spine segments in 3 planes and
 compare them with asymptomatic controls using wearable technology while performing functional
 tasks that patients with chronic low back pain often describe as painful in their daily
 lives.

ICD-10 classifications
Low back painPain in thoracic spineContusion of lower back and pelvisInjuries to the abdomen, lower back, lumbar spine and pelvisSprain and strain of lumbar spine
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06276322
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06276322 through Pure Global AI's free database. This phase not specified trial is sponsored by Hacettepe University and is currently Recruiting. The study focuses on Low Back Pain. Target enrollment is 46 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.